The biotech Athenex (Nasdaq:ATNX) plans to close a facility in Clarence, New York, by March 17, according to a notice from the New York State Department of Labor. It will cut 92 jobs in the process. The company also noted it would close its 503B sterile compounding business to focus on cell therapy. In the third…